Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth C H Fearon

Showing results (21-30 of 86) with videos related to

Pageof 9
Sort By:
International Journal of Oncology|November 13, 2003
Eicosapentaenoic acid perturbs signalling via the NFkappaB transcriptional pathway in pancreatic tumour cellsJames A Ross, Jean P Maingay, Kenneth C H Fearon, et al.
Cancer|April 1, 2005
Serum parathyroid hormone-related peptide is associated with systemic inflammation and adverse prognosis in gastroesophageal carcinomaChris Deans, Stephen Wigmore, Simon Paterson-Brown, et al.
International Journal of Oncology|March 18, 2016
Proteomic identification of potential cancer markers in human urine using subtractive analysisHolger Husi, Richard J E Skipworth, Andrew Cronshaw, et al.
Journal of Genetics|June 17, 2011
Identification of possible genetic polymorphisms involved in cancer cachexia: a systematic reviewBenjamin H L Tan, James A Ross, Stein Kaasa, et al.
Journal of Pain and Symptom Management|March 16, 2007
Objective physical activity and self-reported quality of life in patients receiving palliative chemotherapyMax Dahele, Richard J E Skipworth, Lucy Wall, et al.
World Journal of Surgery|December 2, 2004
Patterns and clinical outcomes associated with routine intravenous sodium and fluid administration after colorectal resectionAndrew L Tambyraja, Fergus Sengupta, Alasdair B MacGregor, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 4, 2009
Physical activity level as an outcome measure for use in cancer cachexia trials: a feasibility studyMatthew Maddocks, Anthony Byrne, Colin D Johnson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2009
Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancerBenjamin H L Tan, Laura A Birdsell, Lisa Martin, et al.
Clinical Science (London, England : 1979)|November 20, 2003
Modulation of the liver export protein synthetic response to feeding by an n-3 fatty-acid-enriched nutritional supplement is associated with anabolism in cachectic cancer patientsMatthew D Barber, Tom Preston, Donald C McMillan, et al.
Clinical Nutrition (Edinburgh, Scotland)|May 18, 2007
Pathophysiology of cancer cachexia: much more than host-tumour interaction?Richard J E Skipworth, Grant D Stewart, Cornelis H C Dejong, et al.
Pageof 9

Showing results (21-30 of 86) with videos related to

Sort By:
Pageof 9
International Journal of Oncology|November 13, 2003
Eicosapentaenoic acid perturbs signalling via the NFkappaB transcriptional pathway in pancreatic tumour cellsJames A Ross, Jean P Maingay, Kenneth C H Fearon, et al.
Cancer|April 1, 2005
Serum parathyroid hormone-related peptide is associated with systemic inflammation and adverse prognosis in gastroesophageal carcinomaChris Deans, Stephen Wigmore, Simon Paterson-Brown, et al.
International Journal of Oncology|March 18, 2016
Proteomic identification of potential cancer markers in human urine using subtractive analysisHolger Husi, Richard J E Skipworth, Andrew Cronshaw, et al.
Journal of Genetics|June 17, 2011
Identification of possible genetic polymorphisms involved in cancer cachexia: a systematic reviewBenjamin H L Tan, James A Ross, Stein Kaasa, et al.
Journal of Pain and Symptom Management|March 16, 2007
Objective physical activity and self-reported quality of life in patients receiving palliative chemotherapyMax Dahele, Richard J E Skipworth, Lucy Wall, et al.
World Journal of Surgery|December 2, 2004
Patterns and clinical outcomes associated with routine intravenous sodium and fluid administration after colorectal resectionAndrew L Tambyraja, Fergus Sengupta, Alasdair B MacGregor, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 4, 2009
Physical activity level as an outcome measure for use in cancer cachexia trials: a feasibility studyMatthew Maddocks, Anthony Byrne, Colin D Johnson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2009
Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancerBenjamin H L Tan, Laura A Birdsell, Lisa Martin, et al.
Clinical Science (London, England : 1979)|November 20, 2003
Modulation of the liver export protein synthetic response to feeding by an n-3 fatty-acid-enriched nutritional supplement is associated with anabolism in cachectic cancer patientsMatthew D Barber, Tom Preston, Donald C McMillan, et al.
Clinical Nutrition (Edinburgh, Scotland)|May 18, 2007
Pathophysiology of cancer cachexia: much more than host-tumour interaction?Richard J E Skipworth, Grant D Stewart, Cornelis H C Dejong, et al.
Pageof 9